“The Dutch government has agreed to grant an export license to allow Ron Fouchier, a virologist at the Erasmus Medical University in Rotterdam, to publish his work on H5N1 avian influenza in Science,” Nature’s “News Blog” reports (Owens, 4/27). “Fouchier had to get permission first from the Dutch Department of Economic Affairs, Agriculture and Innovation — in line with E.U. regulations — because a risk existed that the H5N1 virus, as well as its research, ‘could be used for the wrong purposes,’ the Dutch department said in a statement,” according to Agence France-Presse (4/28).

“The decision by Henk Bleker, minister for agriculture and foreign trade, was announced [Friday] in a press release (Dutch) posted on the ministry’s Web site … four days after a closed meeting in The Hague, where government officials discussed the risks and benefits of the research with an international group of scientists and security experts,” ScienceInsider writes (Enserink, 4/27). The approval comes after the U.S. National Science Advisory Board on Biosecurity last month announced Fouchier’s paper and another on H5N1 could be published in journals, “reversing an earlier decision to withhold key details” from the studies, AFP notes (4/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.